Upcoming Presentations

FOCIS 2007 (FEDERATION OF CLINICAL IMMUNOLOGY SOCIETIES)
San Diego, CA
June 7-11, 2007

From EAE to an MS Clinical Trial: DR2/MOG-35-55 Recombinant T Cell Receptor Ligand (RTL) Treats Relapse of Experimental Encephalomyelitis in DR2 Transgenic Mice

Halina Offner, Dr. Med.
Gregory Burrows, Ph.D.
Jason Link, Ph.D.
Arthur A Vandenbark, Ph.D.
Department of Neurology
Oregon Health & Science University

ADVANCES IN CLINICAL NEUROIMMUNOLOGY
Poznan, Poland
December 7-8, 2007

RTL Therapy in Multiple Sclerosis

Halina Offner, Dr. Med.
Professor of Neurology, Anesthesiology and Perioperative Medicine
Oregon Health & Science University